NEW YORK (GenomeWeb News) – Ingenuity Systems and Affymetrix today announced a deal to co-promote each other's products.

Specifically, the terms of the deal call for the firms to co-promote Ingenuity iReport with Affy's expression microarray products. The combined products, Ingenuity and Affy said, will provide researchers a sample-to-insight continuous workflow "for rapid, confident interpretation of results without the need for bioinformatics experience or support."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.